Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Document And Entity Information

v3.23.2
Document And Entity Information
6 Months Ended
Jun. 30, 2023
Document Information Line Items  
Entity Registrant Name CAN-FITE BIOPHARMA LTD.
Document Type 6-K
Current Fiscal Year End Date --12-31
Amendment Flag false
Entity Central Index Key 0001536196
Document Period End Date Jun. 30, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q2
Entity File Number 001-36203